MedChemExpress, commonly known as MCE, supplies research compounds and life science reagents. Its customers include universities, research institutes, pharmaceutical companies and biotechnology laboratories.
MCE focuses strongly on bioactive molecules and drug discovery tools. Researchers use MCE products to study biological targets, signaling pathways and disease mechanisms.
The portfolio covers early target research, compound screening and preclinical development. It also supports cell experiments, biochemical assays and animal studies.
MCE offers a large selection of inhibitors, agonists and antagonists. These compounds target enzymes, receptors, ion channels and signaling proteins.
Researchers use them to regulate pathway activity and investigate target function. Many products include published biological activity data and supporting references.
The portfolio covers popular pathways such as PI3K/Akt/mTOR, MAPK and JAK/STAT. It also includes compounds for apoptosis, autophagy, ferroptosis and immune signaling.
MCE bioactive compounds include approved drugs, clinical candidates, metabolites and natural products. The range also covers pharmacological tools and experimental small molecules.
Scientists use these products for target validation and mechanism studies. They can also support drug repurposing and structure-activity research.
Product pages usually provide chemical structures, purity data and biological activity information. Storage, solubility and preparation guidance may also be available.
Compound screening libraries are a major part of the MCE portfolio. Researchers can select focused libraries or broader collections for drug discovery.
Available collections include approved drug libraries, natural product libraries and bioactive compound libraries. MCE also offers pathway-focused and disease-focused collections.
These libraries support high-throughput screening and phenotypic screening. They can also help identify lead compounds and new drug indications.
Some libraries focus on cancer, immunity, metabolism or neuroscience. Others target kinases, epigenetic proteins, GPCRs and ion channels.
MCE supplies recombinant proteins for cell biology and drug discovery research. The portfolio includes cytokines, growth factors, enzymes and receptors.
Researchers use these proteins in cell culture, binding studies and functional assays. They also support antibody development and protein interaction studies.
Before ordering, customers should check the expression system and biological activity. Species, tag type, purity and endotoxin level may also affect experimental results.
MCE offers research peptides with different sequences and biological functions. The portfolio includes peptide agonists, antagonists, inhibitors and peptide hormones.
These products support receptor research, signaling studies and drug development. Custom peptide synthesis may be available for selected projects.
Researchers should confirm peptide purity, salt form and solubility before use. Storage and reconstitution conditions can vary between products.
MCE antibodies support target detection and pathway analysis. Available products include primary antibodies, secondary antibodies and selected functional antibodies.
Common applications include western blotting, immunohistochemistry and immunofluorescence. Some antibodies may also support flow cytometry or immunoprecipitation.
Researchers should confirm species reactivity and validated applications before ordering. The recommended dilution can also vary by sample type.
MCE provides biochemical reagents for enzyme assays and cellular research. These products include substrates, probes, dyes, buffers and detection reagents.
Researchers use them to measure enzyme activity, cell viability and oxidative stress. Other applications include apoptosis, metabolism and reporter assays.
These reagents help laboratories build complete workflows around MCE compounds. They also support compound screening and target validation.
MCE offers products for PROTAC and targeted protein degradation research. The portfolio includes PROTAC molecules, linkers, ligands and building blocks.
Researchers can use these tools to design and evaluate protein degraders. Related products support E3 ligase research and degradation pathway studies.
MCE also provides molecular glue degraders and other targeted degradation compounds. These products support emerging drug discovery strategies.
MCE supplies compounds and materials for antibody-drug conjugate research. The range includes ADC payloads, linkers and linker-payload combinations.
These products help researchers design and evaluate new conjugates. They also support oncology research and targeted drug delivery studies.
Customers should review handling and safety information before ordering potent payloads. Some products may require special transport or laboratory controls.
MCE provides many tools for cancer biology and oncology drug discovery. Researchers can study tumor signaling, cell proliferation and metastasis.
The portfolio also supports research into angiogenesis and tumor immunity. Relevant pathways include PI3K/Akt/mTOR, MAPK and DNA damage response.
MCE compound libraries can help laboratories screen potential anticancer drugs. PROTAC and ADC-related products support newer therapeutic strategies.
MCE products support research into cytokines, immune cells and inflammatory pathways. Researchers can investigate innate and adaptive immune responses.
The portfolio covers NF-κB, JAK/STAT, Toll-like receptors and inflammasomes. It also includes compounds for autoimmune and inflammatory disease research.
MCE supplies compounds for neuroscience and neurodegenerative disease research. Key applications include Alzheimer’s disease, Parkinson’s disease and neuroinflammation.
Researchers can study neurotransmitter receptors, ion channels and neuronal signaling. Products also support pain, addiction and behavioral neuroscience research.
MCE provides research tools for glucose metabolism and lipid metabolism. The portfolio also supports obesity, diabetes and mitochondrial research.
Cardiovascular products cover hypertension, thrombosis and vascular biology. Researchers can also study cardiac injury and lipid signaling.
MCE offers compounds for bacterial, viral, fungal and parasitic research. The range includes antimicrobial agents and pathway-specific research tools.
Researchers can use these products for pathogen studies and compound screening. Some libraries focus specifically on infectious disease drug discovery.
MCE has a strong portfolio for regulated cell death research. It includes modulators of apoptosis, autophagy, ferroptosis, necroptosis and pyroptosis.
These products help researchers study cell survival and stress responses. They also support cancer, neuroscience and inflammation research.
MCE products support several stages of drug discovery. Researchers can use them for target validation, hit identification and lead optimization.
Compound libraries enable high-throughput and phenotypic screening. Bioactive compounds also provide reference tools for assay development.
MCE combines compounds, proteins and assay reagents within one portfolio. This range helps researchers create more complete experimental workflows.
Biolterna helps international customers source original MedChemExpress products. Customers can submit the MCE catalog number, specification and required quantity.
We can help confirm product information, availability and storage conditions. We also coordinate international and temperature-controlled shipping.
When an original MCE product is unavailable, Biolterna can help identify alternatives. Customers can compare purity, activity and specifications before ordering.
Official website link：
